Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

PIK3CA inhibition in patients with the CLOVES syndrome

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Targeted therapy in patients with PIK3CA-related overgrowth syndrome

Author(s): Quitterie Venot, Thomas Blanc, Smail Hadj Rabia, Laureline Berteloot, Sophia Ladraa, Jean-Paul Duong, Estelle Blanc, Simon C. Johnson, Clément Hoguin, Olivia Boccara, Sabine Sarnacki, Nathalie Boddaert, Stephanie Pannier, Frank Martinez, Sato Magassa, Junna Yamaguchi, Bertrand Knebelmann, Pierre Merville, Nicolas Grenier, Dominique Joly, Valérie Cormier-Daire, Caroline Michot, Christine Bole-Fey
Published in: Nature, Issue 558/7711, 2018, Page(s) 540-546, ISSN 0028-0836
Publisher: Nature Publishing Group
DOI: 10.1038/s41586-018-0217-9

Intellectual Property Rights

BYL719 (ALPELISIB) FOR USE IN THE TREATMENT OF PIK3CA-RELATED OVERGROWTH SPECTRUM (PROS - CLOVES SYNDROME)

Application/Publication number: EP 17705872
Date: 2017-02-17
Applicant(s): Université Paris Descartes

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available